Have a personal or library account? Click to login
Urinary cotinine cut-off value in categorising cigarette smoking status in healthy pregnant women at term Cover

Urinary cotinine cut-off value in categorising cigarette smoking status in healthy pregnant women at term

Open Access
|Dec 2025

References

  1. Piasek M, Henson MC, Blanuša M, Kostial K. Assessment of steroid disruption and metal concentrations in human placenta: Effects of cigarette smoking. In: Koskinen CJ, editor. Handbook of smoking and health. New York: Nova Science Publishers, Inc.; 2011, p. 325–65
  2. Holbrook BD. The effects of nicotine on human fetal development. Birth Defects Res (Part C) 2016;108:181–92. doi: 10.1002/bdrc.21128
  3. Rogers JM. Smoking and pregnancy: Epigenetics and developmental origins of the metabolic syndrome. Birth Defects Res 2019;111:1259–69. doi: 10.1002/bdr2.1550
  4. Philips EM, Santos S, Trasande L, Aurrekoetxea JJ, Barros H, von Berg A, Bergstrom A, Bird PK, Brescianini S. Changes in parental smoking during pregnancy and risks of adverse birth outcomes and childhood overweight in Europe and North America: an individual participant data meta-analysis of 229,000 singleton births. PLoS Med 2020;17:e1003182. doi: 10.1371/journal.pmed.1003182
  5. Silva AI, Camelo A, Madureira J, Reis AT, Machado AP, Teixeira JP, Costa C. Urinary cotinine assessment of maternal smoking and environmental tobacco smoke exposure status and its associations with perinatal outcomes: a cross-sectional birth study. Environ Res 2022;203:111827. doi: 10.1016/j.envres.2021.111827
  6. Fukuda T, Kyozuka H, Murata T, Yasuda S, Sato A, Ogata Y, Hosoya M, Yasumura S. Urinary cotinine levels versus self-reported smoking status for assessing placental abruption risk: the Japan Environment and Children’s study. J Matern Neonatal Med 2025;38:2497059. doi: 10.1080/14767058.2025.2497059
  7. National Institute on Drug Abuse (NIDA). What are the risks of smoking during pregnancy? [displayed 27 September 2021]. Available at https://nida.nih.gov/publications/research-reports/tobacco-nicotine-e-cigarettes/what-are-risks-smoking-during-pregnancy
  8. Lange S, Probst C, Rehm J, Popova S. National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis. Lancet Glob Heal 2018;6:e769–76. doi: 10.1016/S2214-109X(18)30223-7
  9. Smedberg J, Lupattelli A, Mårdby A, Nordeng H. Characteristics of women who continue smoking during pregnancy: a cross-sectional study of pregnant women and new mothers in 15 European countries. BMC Pregnancy Childbirth 2014;14:213. doi: 10.1186/1471-2393-14-213
  10. Eurostat. Smoking of tobacco products by sex, age and country of citizenship. Last update 2022 [displayed 14 December 2025]. Available at https://ec.europa.eu/eurostat/databrowser/view/hlth_ehis_sk1c/default/table?lang=en. doi: 10.2908/hlth_ehis_sk1c
  11. Ashford K, Wiggins A, Rayens E, Assef S, Fallin A, Rayens MK. Perinatal biochemical confirmation of smoking status by trimester. Nicotine Tob Res 2017;19:631–5. doi: 10.1093/ntr/ntw332
  12. Lupsa I-R, Nunes B, Ligocka D, Elena A, Jakubowski M, Casteleyn L, Aerts D, Biot P, Den Hond E, Castaño A, Esteban M, Kolossa-Gehring M, Fiddicke U, Knudsen LE, Schoeters G, Reis MF. Urinary cotinine levels and environmental tobacco smoke in mothers and children of Romania, Portugal and Poland within the European human biomonitoring pilot study. Environ Res 2015;141:106–17. doi: 10.1016/j.envres.2015.03.018
  13. Florescu A, Ferrenca R, Einarson T, Selby P, Soldin O, Koren G. Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: Focus on developmental toxicology. Ther Drug Monit 2009;31:14–30. doi: 10.1097/FTD.0b013e3181957a3b
  14. Fernandes AGO, Santos LN, Pinheiro GP, Vasconcellos S, Telles de Oliva S, Fernandes BJD, Couto RD. Urinary cotinine as a biomarker of cigarette smoke exposure: a method to differentiate among active, second-hand, and non-smoker circumstances. Open Biomark J 2020;10:60–8. doi: 10.2174/1875318302010010060
  15. Benowitz NL, Bernert JT, Foulds J, Hecht SS, Jacob P, Jarvis MJ, Joseph A, Oncken C, Piper ME. Biochemical verification of tobacco ue and abstinence: 2019 update. Nicotine Tob Res 2020;22:1086–97. doi: 10.1093/ntr/ntz132
  16. Benowitz NL, Hukkanen J, Jacob PI. Nicotine chemistry, metabolism, kinetics and biomarkers. In: Henningfield J, editor. Handbook of experimental pharmacology. Berlin and Heidelberg: Springer-Verlag; 2009, p. 29–60
  17. Dempsey D, Jacob P, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002;301:594–8. doi: 10.1124/jpet.301.2.594
  18. Higgins ST, Heil SH, Badger GJ, Mongeon JA, Solomon LJ, Mchale L, Bernstein IM. Biochemical verification of smoking status in pregnant and recently postpartum women. Exp Clin Psychopharmacol 2007;15:58–66. doi: 10.1037/1064-1297.15.1.58
  19. Piasek M, Škrgatić L, Sulimanec A, Orct T, Sekovanić A, Kovačić J, Katić A, Branović Čakanić K, Pizent A, Brajenović N, Jurič A, Brčić Karačonji I, Kljaković-Gašpić Z, Tariba Lovaković B, Lazarus M, Stasenko S, Miškulin I, Jurasović J. Effects of maternal cigarette smoking on trace element levels and steroidogenesis in the maternal-placental-fetal unit. Toxics 2023;11:714. doi: 10.3390/toxics11080714
  20. Pizent A, Lazarus M, Kovačić J, Tariba Lovaković B, Brčić Karačonji I, Živković Semren T, Sekovanić A, Orct T, Branović-Čakanić K, Brajenović N, Jurič A, Miškulin I, Škrgatić L, Stasenko S, Mioč T, Jurasović J, Piasek M. Cigarette smoking during pregnancy: effects on antioxidant enzymes, metallothionein and trace elements in mother-newborn pairs. Biomolecules 2020;10:892. doi: 10.3390/biom10060892
  21. Brčić Karačonji I, Skender L, Karačić V. Determination of nicotine and cotinine in urine by headspace solid phase microextraction gas chromatography with mass spectrometric detection. Acta Chim Slov 2007;54:74–8.
  22. Štraus B. Medical Biochemistry. Zagreb: Medicinska naklada; 1992
  23. Nishihama Y, Nakayama SF, Tabuchi T, Isobe T, Jung C-R, Iwai-Shimada M, Kobayashi Y, Michikawa T, Sekiyama M, Taniguchi Y, Nitta H, Yamazaki S. Determination of urinary cotinine cut-off concentrations for pregnant women in the Japan Environment and Children’s Study (JECS). Int J Environ Res Public Health 2020;17:5537. doi: 10.3390/ijerph17155537
  24. Stragierowicz J, Mikolajewska K, Zawadzka-Stolarz M, Polanska K, Ligocka D. Estimation of cutoff values of cotinine in urine and saliva for pregnant women in Poland. Biomed Res Int 2013;2013:386784. doi: 10.1155/2013/386784
  25. Benowitz NL, Dains KM, Dempsey D, Herrera B, Yu L, Jacob P 3rd. Urine nicotine metabolite concentrations in relation to plasma cotinine during low-level nicotine exposure. Nicotine Tob Res 2009;11:954–60. doi: 10.1093/ntr/ntp092
  26. Zečić A, Vazdar B, Slišković L, Sutlović D. Urine levels of nicotine and its metabolites in young population exposed to second-hand smoke in nightclubs: a pilot study. Arh Hig Rada Toksikol 2024;75:211–6. doi: 10.2478/aiht-2024-75-3846
  27. Scherer G, Pluym N, Scherer M. Wastewater-based epidemiology (WBE): Potential application for assessing the use of conventional and new generation tobacco and nicotine products. Contrib Tob Nicotine Res 2025;34:59–83. doi: 10.2478/cttr-2025-0007
  28. Scherer G, Pluym N, Scherer M. Intake and uptake of chemicals upon use of various tobacco/nicotine products: can users be differentiated by single or combinations of biomarkers? Contrib Tob Nicotine Res 2021;30:167–98. doi: 10.2478/cttr-2021-0014
  29. Aurrekoetxea JJ, Murcia M, Rebagliato M, López MJ, Castilla AM, Santa-marina L, Guxens M, Fernández-somoano A, Espada M, Lertxundi A, Tardon A, Ballester F. Determinants of self-reported smoking and misclassification during pregnancy, and analysis of optimal cut-off points for urinary cotinine: a cross-sectional study. BMJ Open 2013;3:e002034. doi: 10.1136/bmjopen-2012-002034
  30. England LJ, Grauman A, Qian C, Wilkins DG, Schisterman EF, Yu KF, Levine RJ. Misclassification of maternal smoking status and its effects on an epidemiologic study of pregnancy outcomes. Nicotine Tob Res 2007;9:1005–13. doi: 10.1080/14622200701491255
  31. Maciag MC, Yousuf A, Hauptman M. Impact of prenatal exposure to smoking on child health. Clin Obstet Gynecol 2022;65:388–96. doi: 10.1097/GRF.0000000000000698
  32. Berlin M, Kohn E, Keidar R, Livne A, Marom R, Ovental A, Mandel D, Lubetzky R, Betser M, Moskovich M, Hazan A, Groisman L, Rorman E, Berkovitch M, Matok I, Rosen LJ. Paternal smoking and maternal secondhand smoke exposure and the effects on the offspring: results from the EHF (Environmental Health Fund) birth cohort. Isr J Health Policy Res 2025;14:1–10. doi: 10.1186/s13584-025-00706-3
  33. Taghavi T, Arger CA, Heil SH, Higgins ST, Tyndale RF. Longitudinal influence of pregnancy on nicotine metabolic pathways. J Pharmacol Exp Ther 2018;364:238–45. doi: 10.1124/jpet.117.245126
  34. Brajenović N, Brčić Karačonji I, Mikolić A, Stasenko S, Piasek M. Tobacco smoke and pregnancy: segmental analysis of nicotine in maternal hair. Arch Environ Occup Health 2013;68:117–22. doi: 10.1080/19338244.2012.658121
  35. Jhun H, Seo H, Lee D, Sung M, Kang Y, Syn HC, Jun JK. Self-reported smoking and urinary cotinine levels among pregnant women in Korea and factors associated with smoking during pregnancy. J Korean Med Sci 2010;25:752–7. doi: 10.3346/jkms.2010.25.5.752
  36. Kim S. Overview of cotinine cutoff values for smoking status classification. Int J Environ Res Public Health 2016;13:1236. doi: 10.3390/ijerph13121236
  37. Yang J, Hashemi S, Han W, Song Y, Lim Y. Exposure and risk assessment of second- and third-hand tobacco smoke using urinary cotinine levels in South Korea. Int J Environ Res Public Health 2022;19:3746. doi: 10.3390/ijerph19063746
  38. Pickett KE, Rathouz PJ, Kasza K, Wakschlag LS, Wright R. Self-reported smoking, cotinine levels, and patterns of smoking in pregnancy. Paediatr Perinat Epidemiol 2005;19:368–76. doi: 10.1111/j.1365-3016.2005.00660.x
  39. Zielińska-Danch W, Wardas W, Sobczak A, Szoltysek-Boldys I. Estimation of urinary cotinine cut-off points distinguishing non-smokers, passive and active smokers. Biomarkers 2007;12:484–96. doi: 10.1080/13547500701421341
  40. Kim S, Jung A. Optimum cutoff value of urinary cotinine distinguishing South Korean adult smokers from nonsmokers using data from the KNHANES (2008–2010). Nicotine Tob Res 2013;15:1608–16. doi: 10.1093/ntr/ntt027
DOI: https://doi.org/10.2478/aiht-2025-76-4052 | Journal eISSN: 1848-6312 | Journal ISSN: 0004-1254
Language: English, Croatian, Slovenian
Page range: 251 - 258
Submitted on: Oct 1, 2025
|
Accepted on: Dec 1, 2025
|
Published on: Dec 30, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Nataša Brajenović, Irena Brčić Karačonji, Andreja Jurič, Jelena Kovačić, Sandra Stasenko, Tatjana Mioč, Iva Miškulin, Lana Škrgatić, Martina Piasek, Jasna Jurasović, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution 4.0 License.